Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2

被引:11
|
作者
Kosillo, Polina [1 ]
Ahmed, Kamran M. [1 ]
Aisenberg, Erin E. [2 ]
Karalis, Vasiliki [1 ]
Roberts, Bradley M. [3 ]
Cragg, Stephanie J. [3 ]
Bateup, Helen S. [1 ,2 ,4 ]
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA
[3] Univ Oxford, Dept Physiol Physiol Anat & Genet, Oxford, England
[4] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA
来源
ELIFE | 2022年 / 11卷
基金
美国国家卫生研究院;
关键词
mTORC1; mTORC2; raptor; rictor; dopamine neurons; TSC; Mouse; COMPLEX; 1; TUBEROUS SCLEROSIS; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; MAMMALIAN TARGET; BASAL GANGLIA; BRAIN; AKT; RELEASE; RICTOR;
D O I
10.7554/eLife.75398
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The mTOR pathway is an essential regulator of cell growth and metabolism. Midbrain dopamine neurons are particularly sensitive to mTOR signaling status as activation or inhibition of mTOR alters their morphology and physiology. mTOR exists in two distinct multiprotein complexes termed mTORC1 and mTORC2. How each of these complexes affect dopamine neuron properties, and whether they have similar or distinct functions is unknown. Here, we investigated this in mice with dopamine neuron-specific deletion of Rptor or Rictor, which encode obligatory components of mTORC1 or mTORC2, respectively. We find that inhibition of mTORC1 strongly and broadly impacts dopamine neuron structure and function causing somatodendritic and axonal hypotrophy, increased intrinsic excitability, decreased dopamine production, and impaired dopamine release. In contrast, inhibition of mTORC2 has more subtle effects, with selective alterations to the output of ventral tegmental area dopamine neurons. Disruption of both mTOR complexes leads to pronounced deficits in dopamine release demonstrating the importance of balanced mTORC1 and mTORC2 signaling for dopaminergic function.
引用
收藏
页数:43
相关论文
共 50 条
  • [21] Predominance of mTORC1 over mTORC2 in the Regulation of Proliferation of Ovarian Cancer Cells: Therapeutic Implications
    Carlos Montero, Juan
    Chen, Xi
    Ocana, Alberto
    Pandiella, Atanasio
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (06) : 1342 - 1352
  • [22] ATP-site binding inhibitor effectively targets mTORC1 and mTORC2 complexes in glioblastoma
    Neil, Jayson
    shannon, Craig
    Mohan, Avinash
    Laurent, Dimitri
    Murali, Raj
    Jhanwar-Uniyal, Meena
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (03) : 1045 - 1052
  • [23] Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
    Feldman, Morris E.
    Apsel, Beth
    Uotila, Aino
    Loewith, Robbie
    Knight, Zachary A.
    Ruggero, Davide
    Shokat, Kevan M.
    PLOS BIOLOGY, 2009, 7 (02) : 371 - 383
  • [24] mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells
    Zheng, Bei
    Wang, Jiadan
    Tang, Leilei
    Shi, Jiana
    Zhu, Danyan
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2017, 61 (1-2) : 65 - 72
  • [25] Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation
    Walker, Natalie M.
    Belloli, Elizabeth A.
    Stuckey, Linda
    Chan, Kevin M.
    Lin, Jules
    Lynch, William
    Chang, Andrew
    Mazzoni, Serina M.
    Fingar, Diane C.
    Lama, Vibha N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (12) : 6262 - 6271
  • [26] Dramatic antitumor effects of the dual mTORC1 and mTORC2 inhibitor AZD2014 in hepatocellular carcinoma
    Liao, Hui
    Huang, Yu
    Guo, Botang
    Liang, Bo
    Liu, Xincheng
    Ou, Huohui
    Jiang, Chenglong
    Li, Xianghong
    Yang, Dinghua
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (01): : 125 - 139
  • [27] XPLN is an endogenous inhibitor of mTORC2
    Khanna, Nidhi
    Fang, Yimin
    Yoon, Mee-Sup
    Chen, Jie
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (40) : 15979 - 15984
  • [28] Deconvolution of mTORC2 "in Silico"
    Fingar, Diane C.
    Inoki, Ken
    SCIENCE SIGNALING, 2012, 5 (217)
  • [29] mTORC1 and mTORC2 Differentially Regulate Cell Fate Programs to Coordinate Osteoblastic Differentiation in Mesenchymal Stromal Cells
    Schaub, Theres
    Guergen, Dennis
    Maus, Deborah
    Lange, Claudia
    Tarabykin, Victor
    Dragun, Duska
    Hegner, Bjoern
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [30] LPS Induces mTORC1 and mTORC2 Activation During Monocyte Adhesion
    Ribeiro, Marcelle C.
    Peruchetti, Diogo B.
    Silva, Leandro S.
    Silva-Filho, Joao L.
    Souza, Mariana C.
    Henriques, Maria das Gracas
    Caruso-Neves, Celso
    Pinheiro, Ana Acacia S.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2018, 5